Thomas Rustemeyer

Prof. Dr. Thomas Rustemeyer

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2018 in Contact Dermatitis
Verified
Journal Article
Open access
PDF file
MWMark Wilkinson
Mark Wilkinson
MGMargarida Gonçalo
Margarida Gonçalo
OAOlivier Aerts
Olivier Aerts
SBSonia Badulici
Sonia Badulici
NBNiels H. Bennike
Niels H. Bennike
Wolfgang UterWolfgang Uter
Wolfgang Uter

6 January 2009 in Contact Dermatitis
Verified
Journal Article
Closed access
PDF file
MTMascha J. Toebak
Mascha J. Toebak
SGSusan Gibbs
Susan Gibbs
DBDerk P. Bruynzeel
Derk P. Bruynzeel
RSRik J. Scheper
Rik J. Scheper
TRThomas Rustemeyer
Thomas Rustemeyer

17 January 2023 in Cells
Verified
Journal Article
Open access
PDF file
HKH. Ibrahim Korkmaz
H. Ibrahim Korkmaz
GFGwendolien Flokstra
Gwendolien Flokstra
MWMaaike Waasdorp
Maaike Waasdorp
APAnouk Pijpe
Anouk Pijpe
SPStephan G. Papendorp
Stephan G. Papendorp
PZPaul P. M. van Zuijlen
Paul P. M. van Zuijlen
Burn injury induces a complex inflammatory response, both locally and systemically, and is not yet completely unravelled and understood. In order to enable the development of accurate treatment options, it is of paramount importance to fully understand post-burn immunology. Research in the last decades describes insights into the prolonged and excessive inflammatory response that could exist after both severe and milder burn trauma and that this response differs from that of none-burn acute trauma. Persistent activity of complement, acute phase proteins and pro- and anti-inflammatory mediators, changes in lymphocyte activity, activation of the stress response and infiltration of immune cells have all been related to post-burn local and systemic pathology. This “narrative” review explores the current state of knowledge, focusing on both the local and systemic immunology post-burn, and further questions how it is linked to the clinical outcome. Moreover, it illustrates the complexity of post-burn immunology and the existing gaps in knowledge on underlying mechanisms of burn pathology.

24 June 2022 in Contact Dermatitis
Verified
Journal Article
Open access
Wolfgang UterWolfgang Uter
Wolfgang Uter
SWS. Mark Wilkinson
S. Mark Wilkinson
OAOlivier Aerts
Olivier Aerts
ABAndrea Bauer
Andrea Bauer
LBLeopoldo Borrego
Leopoldo Borrego
AGAnd The Geidac For The Essca And Ebs Escd Working Groups
And The Geidac For The Essca And Ebs Escd Working Groups
Background: Continual analyses of patch test results with the European baseline series (EBS) serve both contact allergy surveillance and auditing the value of included allergens.Objectives: To present results of current EBS patch testing, obtained in 53 departments in 13 European countries during 2019 and 2020.Methods: Anonymised or pseudonymised individual data and partly aggregated data on demographic/clinical characteristics and patch test rest results with the EBS were prospectively collected and centrally pooled and analysed.Results: In 2019 and 2020, 22 581 patients were patch tested with the EBS. Sensitization to nickel remained most common (19.8 [19.2–20.4]% positivity [95% confidence interval]). Fragrance mix I and Myroxylon pereirae yielded very similar results with 6.80 (6.43–7.19)% and 6.62 (6.25–7.00)% positivity, respectively. Formaldehyde at 2% aq. yielded almost one percentage point more positive reactions than 1% concentration (2.49 [2.16–2.85]% vs. 1.59 [1.33–1.88]); methylchloroisothiazolinone/methylisothiazolinone (MCI/MI) and MI alone up to around 5% positives. Among the new additions, propolis was most commonly positive (3.48 [3.16–3.82]%), followed by 2‐hydroxyethyl methacrylate (2.32 [2.0–2.68]%).Conclusion: Ongoing surveillance on the prevalence of contact sensitization contributes to an up‐to‐date baseline series containing the most frequent and/or relevant contact sensitizers for routine patch testing in Europe.

18 September 2020 in Contact Dermatitis
Verified
Journal Article
Open access
PDF file
Wolfgang UterWolfgang Uter
Wolfgang Uter
ABAndrea Bauer
Andrea Bauer
Anna Belloni FortinaAnna Belloni Fortina
Anna Belloni Fortina
ABAndreas J. Bircher
Andreas J. Bircher
RBRichard Brans
Richard Brans
EGESSCA Working Group
ESSCA Working Group
Background: Clinical surveillance of the prevalence of contact allergy in consecutively patch tested patients is a proven instrument to continually assess the importance of contact allergens (haptens) assembled in a baseline series.Objectives: To present current results from the European Surveillance System on Contact Allergies, including 13 countries represented by 1 to 11 departments.Methods: Anonymized or pseudonymized patch test and clinical data from various data capture systems used locally or nationally as transferred to the Erlangen data centre were pooled and descriptively analysed after quality control.Results: In the 4 years (2015‐2018), data from 51 914 patients patch tested with the European baseline series (EBS) of contact allergens were analysed. Contact allergy to nickel was most frequent (17.6% positive), followed by contact allergy to fragrance mix I (6.9%), methylisothiazolinone (MI; 6.2%), andMyroxylon pereiraeresin (balsam of Peru; 5.8%).Conclusions: While the prevalence of MI contact allergy decreased substantially following regulatory intervention, the persistently high levels of allergy to metals, fragrances, other preservatives, and rubber chemicals point to problems needing further research and, potentially, preventive efforts. Results with national additions to the baseline series provide important information on substances possibly to be considered for inclusion in the EBS.

3 September 2004 in Clinical & Experimental Allergy
Verified
Journal Article
Closed access
PDF file
TRThomas Rustemeyer
Thomas Rustemeyer
BBB. M. E. Von Blomberg
B. M. E. Von Blomberg
IHI. M. W. Van Hoogstraten
I. M. W. Van Hoogstraten
DBD. P. Bruynzeel
D. P. Bruynzeel
RSR. J. Scheper
R. J. Scheper